Meridian Bioscience reported $0 in Ordinary Share Capital for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Abbott ABT:US $ 24304M 166M
Accelerate Diagnostics AXDX:US 69K 1000
Atrion ATRI:US 342K 0
Becton, Dickinson and BDX:US $ 365M 0M
Bio Rad Laboratories BIO:US $ 0M 0M
Cerulean Pharma CERU:US $ 0.01M 0M
Cerus CERS:US $ 0.18M 0M
Meridian Bioscience VIVO:US $ 0M 0M
Myriad Genetics MYGN:US $ 0.8M 0M
Orasure Technologies OSUR:US $ 0M 0M
Quidel QDEL:US $ 0.04M 0M
Sientra SIEN:US $ 0.62M 0M
Staar Surgical STAA:US $ 0.48M 0M
Thermo Fisher Scientific TMO:US $ 440M 1M
Trinity Biotech TRIB:US $ 1.44M 0.23M
Utah Medical Products UTMD:US 36K 0